{"id":"https://openalex.org/W2803641","doi":null,"title":"Comparison of a four-drug fixed-dose combination regimen with a single tablet regimen in smear-positive pulmonary tuberculosis.","display_name":"Comparison of a four-drug fixed-dose combination regimen with a single tablet regimen in smear-positive pulmonary tuberculosis.","publication_year":2009,"publication_date":"2009-06-01","ids":{"openalex":"https://openalex.org/W2803641","mag":"2803641","pmid":"https://pubmed.ncbi.nlm.nih.gov/19460254"},"language":"en","primary_location":{"id":"pmid:19460254","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19460254","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease","raw_type":"Comparative Study"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041359017","display_name":"A Bartacek","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Bartacek","raw_affiliation_strings":["Sandoz GmbH, Kundl, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sandoz GmbH, Kundl, Austria","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"D Sch\u00fctt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D Sch\u00fctt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063083051","display_name":"B Panosch","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B Panosch","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"M Borek","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Borek","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.3381,"has_fulltext":false,"cited_by_count":46,"citation_normalized_percentile":{"value":0.86616549,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"13","issue":"6","first_page":"760","last_page":"6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11381","display_name":"Infectious Diseases and Tuberculosis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pulmonary-tuberculosis","display_name":"pulmonary tuberculosis","score":0.8090000152587891},{"id":"https://openalex.org/keywords/smear-positive-pulmonary-tuberculosis","display_name":"smear-positive tuberculosis","score":0.9509999752044678},{"id":"https://openalex.org/keywords/fixed-dose-combination","display_name":"fixed-dose combination","score":0.8550000190734863},{"id":"https://openalex.org/keywords/hrze-regimen","display_name":"HRZE regimen","score":0.6700000166893005},{"id":"https://openalex.org/keywords/isoniazid","display_name":"isoniazid","score":0.9290000200271606},{"id":"https://openalex.org/keywords/rifampicin","display_name":"rifampicin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pyrazinamide","display_name":"pyrazinamide","score":1.0},{"id":"https://openalex.org/keywords/ethambutol","display_name":"ethambutol","score":1.0},{"id":"https://openalex.org/keywords/single-tablet-regimen","display_name":"single-tablet regimen","score":0.7950000166893005},{"id":"https://openalex.org/keywords/sputum-smear-conversion","display_name":"sputum smear conversion","score":0.9150000214576721},{"id":"https://openalex.org/keywords/treatment-acceptability","display_name":"treatment acceptability","score":0.6499999761581421},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7960000038146973},{"id":"https://openalex.org/keywords/non-inferiority","display_name":"non-inferiority","score":0.8560000061988831}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8914728760719299},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.6872914433479309},{"id":"https://openalex.org/C2780459521","wikidata":"https://www.wikidata.org/wiki/Q417571","display_name":"Pyrazinamide","level":4,"score":0.5822087526321411},{"id":"https://openalex.org/C2992435398","wikidata":"https://www.wikidata.org/wiki/Q6934595","display_name":"Multicenter study","level":3,"score":0.45311060547828674},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.33556199073791504},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.31963884830474854},{"id":"https://openalex.org/C2776967927","wikidata":"https://www.wikidata.org/wiki/Q423169","display_name":"Isoniazid","level":3,"score":0.27195996046066284},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.07597240805625916},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000995","descriptor_name":"Antitubercular Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004977","descriptor_name":"Ethambutol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007538","descriptor_name":"Isoniazid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011718","descriptor_name":"Pyrazinamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D012293","descriptor_name":"Rifampin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013183","descriptor_name":"Sputum","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014397","descriptor_name":"Tuberculosis, Pulmonary","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D014397","descriptor_name":"Tuberculosis, Pulmonary","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017060","descriptor_name":"Patient Satisfaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:19460254","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19460254","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease","raw_type":"Comparative Study"},{"id":"mag:2803641","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19460254","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2549861845","https://openalex.org/W1945783329","https://openalex.org/W2913485477","https://openalex.org/W1974043174","https://openalex.org/W2361795112","https://openalex.org/W1846722549","https://openalex.org/W2945001580","https://openalex.org/W3170309302","https://openalex.org/W2086653115","https://openalex.org/W345747312"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"compare":[2],"the":[3,121,124,144,155,172,175,188,194,202],"efficacy,":[4],"safety":[5],"and":[6,16,51,75,83,98,107,110,120,132,148,168,174],"acceptability":[7,122,207],"of":[8,12,71,102,123,160,180,193,201],"two":[9],"short-course":[10],"regimens":[11],"isoniazid,":[13],"rifampicin,":[14],"pyrazinamide":[15],"ethambutol":[17],"(HRZE)":[18],"given":[19],"either":[20],"as":[21,27],"fixed-dose":[22],"combination":[23],"(4-FDC)":[24],"tablets":[25,29],"or":[26,68],"single":[28,69],"(ST)":[30],"in":[31,48,143,154,170],"patients":[32,54],"with":[33,55,117,210],"newly":[34],"diagnosed":[35],"pulmonary":[36],"tuberculosis":[37],"(PTB).":[38],"DESIGN:":[39],"This":[40],"randomised,":[41],"open,":[42],"multicentre,":[43],"multinational":[44],"study":[45],"was":[46,162,197],"conducted":[47],"26":[49],"centres":[50],"included":[52],"1159":[53],"smear-positive":[56],"PTB.":[57],"4-FDC":[58,131,161,195],"daily":[59],"for":[60,65,77,85,130],"2":[61,78],"months":[62,79,87,100,112],"then":[63],"H+R":[64],"4":[66,86,97],"months,":[67],"preparations":[70],"H,":[72],"R,":[73],"Z":[74],"E":[76],"followed":[80],"by":[81],"H":[82],"R":[84],"were":[88,114,136,183],"administered":[89],"daily.":[90],"Sputum":[91],"smear":[92],"conversion":[93,128],"rates":[94,129],"at":[95,108,134,164],"2,":[96,166],"6":[99],"(end":[101],"treatment":[103],"[EOT],":[104],"primary":[105],"endpoint)":[106],"9":[109],"12":[111],"(follow-up)":[113],"measured,":[115],"together":[116],"adverse":[118,181],"events":[119,182],"formulations.":[125],"RESULTS:":[126],"Smear":[127],"ST":[133,203],"EOT":[135,167],"80.4%":[137],"(468/582":[138],"patients)":[139],"vs.":[140,151],"82.7%":[141],"(477/577)":[142],"intent-to-treat":[145],"(ITT)":[146],"population,":[147],"98.1%":[149],"(404/412)":[150],"98.6%":[152],"(416/422)":[153],"per-protocol":[156],"(PP)":[157],"subgroup.":[158],"Non-inferiority":[159],"demonstrated":[163],"month":[165],"follow-up":[169],"both":[171],"ITT":[173],"PP":[176],"populations.":[177],"Overall":[178],"numbers":[179],"not":[184],"significantly":[185,208],"different":[186],"between":[187],"groups.":[189],"CONCLUSION:":[190],"The":[191],"efficacy":[192],"regimen":[196],"non-inferior":[198],"to":[199],"that":[200],"regimens,":[204],"but":[205],"patient":[206],"improved":[209],"4-FDC.":[211]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2016-06-24T00:00:00"}
